Download PDF
Dtsch Med Wochenschr 2005; 130(46): 2653-2656
DOI: 10.1055/s-2005-922050
Übersichten
Hypertensiologie
© Georg Thieme Verlag Stuttgart · New York

Isolierte systolische Hypertonie

Isolated systolic hypertensionM. van der Giet1
  • 1Medizinische Klinik IV - Nephrologie, Charite - Campus Benjamin Franklin, Berlin
Further Information

Publication History

eingereicht: 27.7.2005

akzeptiert: 5.10.2005

Publication Date:
10 November 2005 (online)

Also available at
    Permissions and Reprints

In den letzten Jahren zeigt sich zunehmend im praktischen Alltag eine Form der Hypertonie, die sich durch deutlich erhöhten systolischen Blutdruck bei normalem diastolischem Blutdruck äußert. Patienten klagen bei dieser Art des Hochdrucks immer wieder über sehr stark schwankende und zum Teil medikamentös nur schwer einstellbare Blutdruckwerte. Sowohl Patienten wie auch die behandelnde Ärzte verzweifeln nicht selten an dieser Blutdruckkonstellation. Nach den WHO Guidelines und auch den Empfehlungen der deutschen und europäischen Hochdruckgesellschaften wird ein erhöhter systolischer Blutdruck über 140 mmHg bei gleichzeitig normalen diastolischen Blutdruck unter 90 mmHg als isolierte systolische Hypertonie (ISH) bezeichnet. Typisches Charakteristikum ist der erhöhte Pulsdruck, der sich aus der Differenz von systolischem und diastolischen Blutdruck errechnen lässt. Sowohl die isolierte systolische Hypertonie wie aber auch der erhöhte Pulsdruck sind unabhängige Risikofaktoren für kardiovaskuläre Folgeerkrankungen.

kurzgefasst: Eine isolierte systolische Hypertonie liegt vor, wenn der systolische Blutdruck über 140 mmHg liegt und der diastolische Blutdruck unter 90 mmHg bleibt. Eine typische Begleiterscheinung ist der erhöhte Pulsdruck, der sich aus der Differenz von systolischem und diastolischen Blutdruck berechnen lässt. Beides sind unabhängige kardiovaskuläre Risikofaktoren.

Literatur

  • 1 The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group . Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension.  J Clin Epidemiol. 1988;  41 1197-1208
    Google Scholar
  • 2 SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP).  Jama. 1991;  265 3255-3264
    Google Scholar
  • 3 Arking D E, Atzmon G, Arking A, Barzilai N, Dietz H C. Association between the functional variant of KLOTHO allele and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.  Circ Res. 2005;  96 412-418
    Google Scholar
  • 4 Asmar R, Gosse P, Topouchian J, N’Tela G, Dudley A, Shepherd G L. Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension.  J Renin Angiotensin Aldosterone Syst. 2002;  3 176-180
    Google Scholar
  • 5 Asmar R, Hugues C, Pannier B, Daou J, Safar M E. Duration of action of bisoprolol after cessation of a 4 week treatment and its influence on pulse wave velocity and aortic diameter: a pilot study in hypertensive patients.  Eur Heart J. 1987;  8 (Suppl M) 115-120
    Google Scholar
  • 6 Asmar R G, London G M, O’Rourke M E, Safar M E. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.  Hypertension. 2001;  38 922-926
    Google Scholar
  • 7 Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification.  Cardiovasc Pathol. 2004;  13 146-155
    Google Scholar
  • 8 Benetos A et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period.  Circulation. 2002;  105 1202-1207
    Google Scholar
  • 9 Benetos A, Vasmant D, Thiery P, Safar M. Effects of ramipril on arterial hemodynamics.  J Cardiovasc Pharmacol. 1991;  18 S153-156 (Suppl 2)
    Google Scholar
  • 10 Blacher J, Raison J, Amah G, Schiemann A L, Stimpel M, Safar M E. Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril.  Cardiovasc Drugs Ther. 1998;  12 409-414
    Google Scholar
  • 11 Blacher J, Staessen J A, Girerd X, Gasowski J, Thijs L, Liu L, Wang J G, Fagard R H, Safar M E. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.  Arch Intern Med. 2000;  160 1085-1089
    Google Scholar
  • 12 Bortolotto L A, Safar M E, Billaud E, Lacroix C, Asmar R, London G M, Blacher J. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients.  Hypertension. 1999;  34 837-842
    Google Scholar
  • 13 Burt V L, Cutler J A, Higgins M, Horan M J, Labarthe D, Whelton P, Brown C, Roccella E J. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.  Hypertension. 1995;  26 60-69
    Google Scholar
  • 14 Burt V L, Whelton P, Roccella E J, Brown C, Cutler J A, Higgins M, Horan M J, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988 - 1991.  Hypertension. 1995;  25 305-313
    Google Scholar
  • 15 Chae C U, Pfeffer M A, Glynn R J, Mitchell G F, Taylor J O, Hennekens C H. Increased pulse pressure and risk of heart failure in the elderly.  Jama. 1999;  281 634-639
    Google Scholar
  • 16 Domanski M J, Davis B R, Pfeffer M A, Kastantin M, Mitchell G F. Isolated systolic hypertension: prognostic information provided by pulse pressure.  Hypertension. 1999;  34 375-380
    Google Scholar
  • 17 Ferrier K E, Muhlmann M H, Baguet J P, Cameron J D, Jennings G L, Dart A M, Kingwell B A. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension.  J Am Coll Cardiol. 2002;  39 1020-1025
    Google Scholar
  • 18 Franklin S S, Gustin W t, Wong N D, Larson M G, Weber M A, Kannel W B, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study.  Circulation. 1997;  96 308-315
    Google Scholar
  • 19 Franklin S S, Khan S A, Wong N D, Larson M G, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.  Circulation. 1999;  100 354-360
    Google Scholar
  • 20 Izzo J L, Shykoff B E. Arterial stiffness: clinical relevance, measurement, and treatment.  Rev Cardiovasc Med. 2001;  2 29-34, 37 - 40
    Google Scholar
  • 21 Kannel W B, Gordon T, Schwartz M J. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.  Am J Cardiol. 1971;  27 335-346
    Google Scholar
  • 22 Kass D A, Shapiro E P, Kawaguchi M, Capriotti A R, Scuteri A, deGroof R C, Lakatta E G. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.  Circulation. 2001;  104 1464-1470
    Google Scholar
  • 23 Komai N, Ohishi M, Moriguchi A. et al . Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation.  Hypertens Res. 2002;  25 5-10
    Google Scholar
  • 24 Kostis J B, Lawrence-Nelson J, Ranjan R, Wilson A C, Kostis W J, Lacy C R. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group.  Am J Hypertens. 2001;  14 798-803
    Google Scholar
  • 25 Kuro-o M, Matsumura Y. et al . Mutation of the mouse klotho gene leads to a syndrome resembling ageing.  Nature. 1997;  390 45-51
    Google Scholar
  • 26 Lehmann E D. Terminology for the definition of arterial elastic properties.  Pathol Biol (Paris). 1999;  47 656-664
    Google Scholar
  • 27 Lichtenstein M J, Shipley M J, Rose G. Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study.  Br Med J (Clin Res Ed). 1985;  291 243-245
    Google Scholar
  • 28 Liu L, Wang J G, Gong L, Liu G, Staessen J A. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.  J Hypertens. 1998;  16 1823-1829
    Google Scholar
  • 29 McEniery C M, Wallace S, Dakham Z, Pusalkar P, Ashby M J, Cockcroft J R, Wilkinson I B. Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness.  Arterioscler Thromb Vasc Biol. 2005;  25 372-378
    Google Scholar
  • 30 Mitchell G F, Parise H, Benjamin E J, Larson M G, Keyes M J, Vita J A, Vasan R S, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.  Hypertension. 2004;  43 1239-1245
    Google Scholar
  • 31 Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure.  Am J Hypertens. 2004;  17 118-123
    Google Scholar
  • 32 Neaton J D, Blackburn H. et al . Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.  Arch Intern Med. 1992;  152 1490-1500
    Google Scholar
  • 33 Nicholls W W, Avolioa A P, Kelly R P. Effects of age and of hypertension on wave travel and reflections. London: Edward Arnold In: O’Rourke MF, Safa M, dzau VJ, eds. Arterial vasodilation: mechanisms and therapy 1993: 23-40
    Google Scholar
  • 34 Nurnberger J, Opazo Saez A, Dammer S, Mitchell A, Wenzel R R, Philipp T, Schafers R F. Left ventricular ejection time: a potential determinant of pulse wave velocity in young, healthy males.  J Hypertens. 2003;  21 2125-2132
    Google Scholar
  • 35 Robert L. Aging of the vascular-wall and atherosclerosis.  Exp Gerontol. 1999;  34 491-501
    Google Scholar
  • 36 Rutan G H, Kuller L H, Neaton J D, Wentworth D N, McDonald R H, Smith W M. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial.  Circulation. 1988;  77 504-514
    Google Scholar
  • 37 Seals D R. et al . Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness.  J Am Coll Cardiol. 2001;  38 506-513
    Google Scholar
  • 38 Staessen J A, Fagard R. et al . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.  Lancet. 1997;  350 757-764
    Google Scholar
  • 39 Staessen J A. et al . Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.  Lancet. 2000;  355 865-872
    Google Scholar
  • 40 Tavli T, Kozan O, Cin V G, Dogan A, Gokcin A. The effects of nisoldipine on carotid artery stiffness and left ventricular functions.  Jpn Heart J. 1995;  36 629-637
    Google Scholar
  • 41 Tomiyama H. et al . Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12 517 subjects.  Atherosclerosis. 2003;  166 303-309
    Google Scholar
  • 42 Vaccarino V, Holford T R, Krumholz H M. Pulse pressure and risk for myocardial infarction and heart failure in the elderly.  J Am Coll Cardiol. 2000;  36 130-138
    Google Scholar
  • 43 Wilking S V, Belanger A, Kannel W B, D’Agostino R B, Steel K. Determinants of isolated systolic hypertension.  J Am Med Assoc. 1988;  260 3451-3455
    Google Scholar

Prof. Dr. med. Markus van der Giet

Charite - Campus Benjamin Franklin, Medizinische Klinik IV - Nephrologie

Hindenburgdamm 30

12200 Berlin

Phone: +4930/84453021

Fax: +4930/84453338

Email: markus.vandergiet@charite.de

      >